Stockscreener 앱 받기
0.6407
10.47%
0.0607
시간 외 거래:
.50
-0.1407
-21.96%
Briacell Therapeutics Corp 주식(BCTX)의 최신 뉴스
BriaCell Therapeutics (OTCMKTS:BCTXF) Shares Up 2.7% – Here’s Why - Defense World
BriaCell Announces Proposed Effective Date of Share Consolidation - The Manila Times
BriaCell Announces 15:1 Share Consolidation to Maintain Nasdaq Listing Compliance - StockTitan
Bullish BriaCell Therapeutics Insider Buying Worth US$5.52m Yet To Pay Off - Simply Wall St
Insider Purchases Worth US$5.52m See Losses As BriaCell Therapeutics Market Value Drops To CA$40m - Yahoo Finance
BCTXBriacell Therapeutics Corp. Common Shares Latest Stock News & Market Updates - StockTitan
BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures - GlobeNewswire
BriaPro Therapeutics Corp. Announces Availability of Annual - GlobeNewswire
BriaPro Therapeutics Announces Digital Voting Process for 2025 Annual Meeting Amid Postal Strike - StockTitan
Vancouver biotech BriaCell to raise US$5.5 million in share offering - Business in Vancouver
BriaCell Therapeutics Corp. Reports Earnings Results for the First Quarter Ended October 31, 2024 - Marketscreener.com
BriaCell Therapeutics Corp. (BCTX) reports earnings - Quartz
BriaCell Therapeutics Reports Quarterly Financial Loss - TipRanks
BriaCell Therapeutics (OTCMKTS:BCTXF) and AbbVie (NYSE:ABBV) Head-To-Head Comparison - Defense World
BriaCell Therapeutics’ (BCTX) “Buy” Rating Reiterated at HC Wainwright - Defense World
BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering - The Manila Times
BriaCell Therapeutics (CVE:BCT) Trading Down 3.8% – Here’s What Happened - Defense World
Briacell Therapeutics Corp (BCTX-Q) QuotePress Release - The Globe and Mail
BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ - GlobeNewswire
BriaCell's Groundbreaking Cancer Treatment Shows Promise in Converting 'Cold' Tumors to 'Hot' in Clinical Trial - StockTitan
BriaCell Therapeutics Announces $5.5M Public Offering with 5-Year Warrants at $0.75 Per Share - StockTitan
BriaCell announces public offering of shares and warrants By Investing.com - Investing.com South Africa
BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering - The Manila Times
Certain Warrants of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 12-DEC-2024. - Marketscreener.com
BriaCell announces public offering of shares and warrants - Investing.com
BriaCell Therapeutics Announces Proposed Public Offering - GlobeNewswire
BriaCell Therapeutics Launches Public Offering of Shares and Warrants to Fund Growth Initiatives - StockTitan
BriaCell Presents Unprecedented Overall Survival Data in - GlobeNewswire
BriaCell's Cancer Immunotherapy Shows Breakthrough Results: Doubles Survival in Phase 2 Trial - StockTitan
HC Wainwright Analysts Lift Earnings Estimates for TSE:BCT - Defense World
HC Wainwright Reiterates Buy Rating for BriaCell Therapeutics (NASDAQ:BCTX) - Defense World
BriaCell Therapeutics (NASDAQ:BCTXW) Trading Up 12.2% – Here’s Why - Defense World
H.C. Wainwright reiterates Buy rating on Briacell Therapeutics stock - Investing.com
Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend - Benzinga
BriaCell Receives Green-Light from Data Safety Monitoring Board for Its Phase 3 Study in Metastatic Breast Cancer - Marketscreener.com
BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer - GlobeNewswire
BriaCell's Phase 3 Cancer Trial Clears Key Safety Review for Breast Cancer Treatment - StockTitan
BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive - GlobeNewswire
BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer - The Manila Times
BriaCell's Breast Cancer Therapy Shows 13.4-Month Survival Rate in Phase 2 Trial | BCTX Stock News - StockTitan
BriaCell announces board member resignation - Investing.com
BriaCell announces board member resignation By Investing.com - Investing.com UK
BriaCell Provides Update to its Board of Directors - The Manila Times
BriaCell Therapeutics Director Marc Lustig Steps Down from Board, Effective Immediately | BCTXW Stock News - StockTitan
BriaCell Therapeutics Corp. (BCT.TO) latest stock news and headlines - Yahoo Finance UK
U.S. Dollar/Rwanda Rwanda Francs (USDRWF) QuotePress Release - The Globe and Mail
BriaCell begins phase 1/2 trial of Bria-OTS™ for breast cancer | 2024-11-21 | Investing News - Stockhouse Publishing
BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study - GlobeNewswire
BriaCell Launches Phase 1/2 Trial of Next-Gen Breast Cancer Immunotherapy | BCTX Stock News - StockTitan
Global X Equal Wght CDN Oil Gas Indx ETF (NRGY-T) QuotePress Release - The Globe and Mail
Global X Equal Weight Canadian Groceries & Stapl (MART-T) QuotePress Release - The Globe and Mail
0.60%
2.24%
자본화:
|
볼륨(24시간):